| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Capsaicin |
| Brand | Qutenza® |
| Indication | Peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain. |
| Assessment Process | |
| Rapid review commissioned | 15/06/2012 |
| Rapid review completed | 28/06/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.